Toxicity outcomes of concurrent radiotherapy with adjuvant capecitabine in triple-negative breast cancer (TROD 06-24)

Abstract Purpose Triple-negative breast cancer (TNBC), the subtype with the poorest prognosis, shows treatment outcomes closely tied to the response to neoadjuvant chemotherapy. Patients with residual disease post-treatment face a higher recurrence risk. In this subgroup, adjuvant capecitabine has b...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Volkan Demircan, Berrin Benli Yavuz, Bekir Hakan Bakkal, Sukran Celikarslan, Sule Karabulut Gul, Huseyin Tepetam, Didem Colpan Oksuz, Alaettin Arslan, Ayse Altinok
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Springer 2026-06-01
Serie:	Discover Oncology
Soggetti:	Radiotherapy Capecitabine Triple negative breast cancer Side effects Toxicity
Accesso online:	https://doi.org/10.1007/s12672-026-05481-4
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!